Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Yerushalmi

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Harefuah|January 7, 1998
[Syncope induced by cardiovascular drugs]Y Edoute, R Yerushalmi
The Israel Medical Association Journal : IMAJ|August 4, 2015
PAGET'S DISEASE AND MALE BREAST CANCERR Yerushalmi, A Sulkes
Leukemia & Lymphoma|May 1, 1996
A patient with Werner's syndrome and erythroleukemia: just coincidence?C Bartal, R Yerushalmi, D Zilberman, et al.
Chemical Communications (Cambridge, England)|March 13, 2015
Salting-in effect in organic dispersions of poly(3-hexyl thiophene)-carbon-nanotubesC Bounioux, A Bar-Hen, R Yerushalmi-Rozen
Science (New York, N.Y.)|February 11, 1994
Suppression of rupture in thin, nonwetting liquid filmsR Yerushalmi-Rozen, J Klein, L J Fetters
Acta Cytologica|September 26, 1997
Diagnosis of fibroadenoma in breast fine needle aspirates devoid of typical stromaE Malberger, R Yerushalmi, A Tamir, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 16, 2009
Breast carcinoma--rare types: review of the literatureR Yerushalmi, M M Hayes, K A Gelmon
Leukemia|February 12, 2010
Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: long-term follow-upA Shimoni, I Hardan, N Shem-Tov, et al.
Bone Marrow Transplantation|August 4, 2015
Fludarabine and treosulfan compared with other reduced-intensity conditioning regimens for allogeneic stem cell transplantation in patients with lymphoid malignanciesR Yerushalmi, N Shem-Tov, I Danylesko, et al.
Bone Marrow Transplantation|February 14, 2012
Allo-SCT for AML and MDS with treosulfan compared with BU-based regimens: reduced toxicity vs reduced intensityA Shimoni, N Shem-Tov, Y Volchek, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Harefuah|January 7, 1998
[Syncope induced by cardiovascular drugs]Y Edoute, R Yerushalmi
The Israel Medical Association Journal : IMAJ|August 4, 2015
PAGET'S DISEASE AND MALE BREAST CANCERR Yerushalmi, A Sulkes
Leukemia & Lymphoma|May 1, 1996
A patient with Werner's syndrome and erythroleukemia: just coincidence?C Bartal, R Yerushalmi, D Zilberman, et al.
Chemical Communications (Cambridge, England)|March 13, 2015
Salting-in effect in organic dispersions of poly(3-hexyl thiophene)-carbon-nanotubesC Bounioux, A Bar-Hen, R Yerushalmi-Rozen
Science (New York, N.Y.)|February 11, 1994
Suppression of rupture in thin, nonwetting liquid filmsR Yerushalmi-Rozen, J Klein, L J Fetters
Acta Cytologica|September 26, 1997
Diagnosis of fibroadenoma in breast fine needle aspirates devoid of typical stromaE Malberger, R Yerushalmi, A Tamir, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 16, 2009
Breast carcinoma--rare types: review of the literatureR Yerushalmi, M M Hayes, K A Gelmon
Leukemia|February 12, 2010
Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: long-term follow-upA Shimoni, I Hardan, N Shem-Tov, et al.
Bone Marrow Transplantation|August 4, 2015
Fludarabine and treosulfan compared with other reduced-intensity conditioning regimens for allogeneic stem cell transplantation in patients with lymphoid malignanciesR Yerushalmi, N Shem-Tov, I Danylesko, et al.
Bone Marrow Transplantation|February 14, 2012
Allo-SCT for AML and MDS with treosulfan compared with BU-based regimens: reduced toxicity vs reduced intensityA Shimoni, N Shem-Tov, Y Volchek, et al.
Pageof 4